Joana Carvalho, PhD, managing science editor —

Joana holds a bachelor’s in biology, a Master of Science in evolutionary and developmental biology, and a PhD in biomedical sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — those that make up the lining of blood vessels — found in the umbilical cord of newborns. In addition to several research fellowships, she was awarded two Erasmus scholarships to conduct part of her studies in France.

Articles by Joana Carvalho

Scientists Discover Two Distinct Symptom Profiles in HD Patients

People with Huntington’s disease may have two different symptom profiles, a cognitive-motor and a psychiatric profile, associated with different clinical and neurobiological features. The findings of the study, “Specific patterns of brain alterations underlie distinct clinical profiles in Huntington’s disease,” were published in NeuroImage: Clinical. Huntington’s…

Metformin Reversed Symptoms Associated with Huntington’s Disease in Mouse Study

Researchers narrowing in on early neuronal functioning stages of development, well before Huntington’s disease symptoms appear, believe they have found a potentially important path to intervening with the diabetes medication metformin. Their research was conducted in a mouse model of the disease. Metformin, an oral medication normally prescribed to patients…

Time Perception Impaired in Huntington’s Patients, and Linked to Disease Severity, Study Finds

Time perception is impaired in patients with Huntington’s disease, even in pre- or early-symptomatic stages of the disease, and is correlated with disease severity and progression, Swiss researchers found. The study, “Auditory time perception in Huntington’s disease,” was published in Neuropsychologia. Huntington’s disease is a genetic neurodegenerative disorder…

Autophagy Affects Protein Accumulation, Gene Activity in Huntington’s, Study Finds

Researchers have found a direct link between abnormal protein accumulation in nerve cells — a hallmark of several neurodegenerative diseases, such as Parkinson’s and Alzheimer’s — and the regulation of gene activity in Huntington’s disease. According to researchers, both processes are influenced by autophagy, a mechanism used by cells to break…

Early White Matter Alterations Are Clinically Relevant in Huntington’s Patients, Study Shows

Changes in the brain’s white matter in early Huntington’s disease can reflect a process that’s clinically relevant and might be linked to early cognitive dysfunction, according to researchers from Harvard Medical School. Their study, “Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease,” was published in…